Work

Impact of β-Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study

Year: 2026

Type: article

Study design: Observational Study

Source: Cancer Epidemiology Biomarkers & Prevention

DOI: 10.1158/1055-9965.epi-26-0062

Authors: Jason Cham, Eunyoung Yang, Jiheum Park, Ruth A. White, Tito Fojo, Keith Sigel, Susan E. Bates

Institutions: Columbia University Irving Medical Center, James J. Peters VA Medical Center, Icahn School of Medicine at Mount Sinai, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, National Cancer Institute

Awards: MODULATING NEURAL SIGNALING IN THE TREATMENT OF PANCREATIC CANCER, G9000359106, Cancer Center Support Grant

OpenAlex ID: W7203715820

FWCI:

Cites:

Cited by:

Related to: